Status:

RECRUITING

Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Intracerebral Hemorrhage

Eligibility:

All Genders

20-80 years

Phase:

PHASE2

Brief Summary

This trial is a phase IIa human clinical study, in which 60 patients with intracerebral hemorrhage (ICH) at basal ganglion or thalamus within 6 h after onset will be enrolled. Patients will be randoml...

Detailed Description

A phase IIa human clinical trial will be performed to clarify the safety and efficacy of using usual dose of celecoxib (200 mg/day) for 21 days starting within 6 hours after onset of ICH. Totally 60 p...

Eligibility Criteria

Inclusion

  • Acute ICH patients able to take the first dose within 6 hours after onset
  • ICH location at basal ganglion or thalamus
  • ICH volume \< 30 mL
  • Normal renal function (creatinine \[Cr\] ≤ 1.3 mg/dL)
  • No surgical indication
  • Signed informed consent
  • Consciousness clear or mild drowsiness
  • Age 20-80 years old

Exclusion

  • Allergy to celecoxib or other non-steroid anti-inflammatory drugs (NSAIDs)
  • Post-coronary artery bypass graft (CABG) within 14 days
  • Previous myocardial infarction
  • Previous peptic ulcer disease
  • Abnormal renal function (Cr \> 1.3 mg/dL)
  • Surgery for this ICH
  • Pregnancy or under breast feeding (If the female case is not sure about pregnancy, pregnancy test will be performed)
  • Premorbid mRS \> or = 3
  • Previous ICH not at basal ganglia or thalamus
  • Coagulation abnormality (abnormal PT/PTT), or taking anticoagulant or antiplatelet
  • Abnormal liver function (ALT \> 3x upper limit)
  • History of severe bleeding event, requiring admission or blood transfusion
  • History of stenting or valve replacement, requiring long-term using antithrombotics

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05434065

Start Date

January 1 2023

End Date

December 31 2027

Last Update

September 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Natinal Taiwan University Hospital

Taipei, Taiwan, 100